Last reviewed · How we verify

NCT03766464

Aspects Associated With Obstructive Sleep Apnea, Bruxism and Orofacial Pain

Completed Last updated 29 March 2022
What this trial tests

trial testing Evaluation of TMD and pain sensitivity in Bruxism in 80 participants. Completed in 1 January 2022.

Timeline
1 January 2019
Primary endpoint
1 June 2021
1 January 2022

Quick facts

Lead sponsorFederal University of Pelotas
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date1 January 2019
Primary completion1 June 2021
Estimated completion1 January 2022
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Federal University of Pelotas

Who can join

Adults 20 to 80, any sex, with Bruxism or Temporomandibular Joint Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluated the influence of the sleep bruxism (SB), awake bruxism (AB) and obstructive sleep apnea syndrome (OSAS) on the signs and symptoms of temporomandibular disorders (TMD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bruxism

Currently open trials in the same condition.

Other Federal University of Pelotas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03766464.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing